New Weight Loss Study Finds Zepbound Outperforms Ozempic & Wegovy

REUTERS/Brendan McDermid/File Photo

Ally Reid

Tuesday, July 9th, 2024 10:46am

A new weight loss study has found that drug brands Zepbound and Mounjaro led to more weight loss compared to Ozempic and Wegovy. The active ingredient in Zepbound and Mounjaro is tirzepatide, while the active ingredient in Ozempic and Wegovy is semaglutide. This new study published by JAMA Internal Medicine found patients taking the highest Zepbound dose lost about 21% of their body weight during a 72-week period. Meanwhile, patients on the highest dose of Wegovy lost around 15% of their body weight during a 68-week period. Do you or anyone you know take any of the new weight loss drugs? What has been your or their experience with them?

Latest Posts

What's Happening

  • Your Home Sold Guaranteed Radio

    The Your Home Sold Guaranteed Radio Show where you get advice you can trust from the capital region’s leading experts in real estate and all related fields.

  • Herzog Law Firm

    Listen Saturday mornings from 8am-9am for The Estate and Medicaid Planning Hour with Herzog Law Firm.

  • Madison Wealth Managers

    Join Madison Wealth Managers for the ‘Planning for Prosperity Show’ Saturday mornings from 10am-11am on Magic 590 & 100.5.


100.5 FM & 590AM